Wang Chuan, Chen Jun, Gu Chengxiong, Li Jingxing
Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
People's Hospital of Deyang City, Sichuan, China.
Interact Cardiovasc Thorac Surg. 2019 Sep 1;29(3):393-401. doi: 10.1093/icvts/ivz125.
The aim of this analysis was to compare survival outcomes of coronary endarterectomy (CE) combined with coronary artery bypass grafting (CABG) with those of conventional CABG.
Eight observational studies were included in this analysis, including 10 529 different patients in Asia, Europe and North America, from 1985 to 2012, among whom 1925 underwent CE + CAGB and 8604 underwent conventional CAGB. The follow-up period ranged from 4 to 14 years. This meta-analysis was performed with the fixed-effects model.
After rigorous assessment of the quality of the studies included, this analysis showed that CE + CABG had a statistically significant weaker short-term outcome, with a higher risk of mortality [odds ratio (OR)] 1.61; P = 0.002]. Further, this phenomenon was exacerbated in the midterm. One-year and 2-year results indicated that death was, respectively, 163% (OR 2.63; P < 0.001) and 133% (OR 2.60; P < 0.001) more likely to occur in the CE + CABG group. However, the long-term results indicated no difference between the 2 groups. The 4-year hazard ratio (1.13; P = 0.10) did not show significant differences between the groups, and the Kaplan-Meier survival curves had the same level and pattern.
CE + CABG had a significantly weaker short-term outcome than conventional CABG, and this trend continued in the midterm. The survival rate had the largest gap in the midterm. However, there was no significant difference between these 2 groups in the long run.
本分析旨在比较冠状动脉内膜切除术(CE)联合冠状动脉旁路移植术(CABG)与传统CABG的生存结果。
本分析纳入了8项观察性研究,包括1985年至2012年在亚洲、欧洲和北美的10529例不同患者,其中1925例行CE + CAGB,8604例行传统CAGB。随访期为4至14年。本荟萃分析采用固定效应模型。
在对纳入研究的质量进行严格评估后,本分析表明,CE + CABG的短期结果在统计学上显著较差,死亡风险更高[优势比(OR)为1.61;P = 0.002]。此外,这种现象在中期加剧。1年和2年的结果表明,CE + CABG组死亡发生的可能性分别高出163%(OR 2.63;P < 0.001)和133%(OR 2.60;P < 0.001)。然而,长期结果表明两组之间没有差异。4年风险比(1.13;P = 0.10)在两组之间未显示出显著差异,Kaplan-Meier生存曲线具有相同的水平和模式。
CE + CABG的短期结果明显比传统CABG差,这种趋势在中期持续存在。中期生存率差距最大。然而,从长远来看,这两组之间没有显著差异。